欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/H/1943/001
药品名称
Albumeon
活性成分
albumin human 200.0 g/l
剂型
Solution for infusion
上市许可持有人
CSL Behring GmbH Emil-von-Behring-Straße 76 35041 Marburg
参考成员国 - 产品名称
Germany (DE)
Albumeon
互认成员国 - 产品名称
Luxembourg (LU)
Lithuania (LT)
Human Albumin CSL Behring 200 g/l infuzinis tirpalas
Ireland (IE)
Iceland (IS)
France (FR)
Estonia (EE)
Belgium (BE)
Croatia (HR)
Slovenia (SI)
Slovakia (SK)
Human Albumin CSL Behring 200 g/l
Romania (RO)
Albumeon 200 g/l soluţie perfuzabilă
Czechia (CZ)
Human Albumin CSL Behring 200 g/l
Cyprus (CY)
ALBUMEON SOL FOR INF
Bulgaria (BG)
Hungary (HU)
HUMAN ALBUMIN CSL BEHRING 200 g/l oldatos infúzió
Poland (PL)
Human Albumin CSL Behring 200 g/l
Finland (FI)
Norway (NO)
Albumin Behring
Greece (GR)
ALBUMEON
Italy (IT)
Portugal (PT)
Spain (ES)
Austria (AT)
Denmark (DK)
United Kingdom (Northern Ireland) (XI)
Netherlands (NL)
Malta (MT)
Albumeon® 20, 200 g/l solution for infusion
Latvia (LV)
Human Albumin CSL Behring 200 g/l šķīdums infūzijām
许可日期
2014/06/18
最近更新日期
2024/08/10
药物ATC编码
B05AA01 albumin
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Biological: Blood Product
TypeLevel5:
Prescription Only
附件文件下载
Final Labelling
|
Albumeon_EU_LAB_09_OCT_2013_blank_b9eb9e
Date of last change:2024/09/06
Final PL
|
Albumeon_EU_PI_10_JUN_2014_blank_19d22c
Date of last change:2024/09/06
Final SPC
|
Albumeon_EU_SPC_06_JUN_2014_blank_67b209
Date of last change:2024/09/06
Final Product Information
|
common_outer_blank
Date of last change:2024/09/06
Final Product Information
|
common_pl_blank
Date of last change:2024/09/06
Final Product Information
|
common_spc_blank
Date of last change:2024/09/06
PubAR
|
EPAR_Update_Albumeon_2021
Date of last change:2024/09/06
PubAR Summary
|
Summary PAR Albumeon_220415
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase